|
1. World Health Organization: The top 10 causes of death. Health topics: Mortality. 2017. 2. World Health Organization: Global health estimates summary tables: projection of deaths by cause, age and sex, by world bank income group and who region. Projections of mortality and causes of death, 2015 and 2030. 2013. 3. Thygesen K, Alpert J and White H: Universal definition of myocardial infarction. European Heart Journal 2007, 28:2525–2538. 4. Matsui Y, Morimoto J and Uede T: Role of matricellular proteins in cardiac tissue remodeling after myocardial infarction. World J Biol Chem 2010, 1(5):69-80. 5. Shah A, Anand A, Sandoval Y, et al.: High-sensitivity cardiac troponin I at presentation in patients with suspected acute coronary syndrome: a cohort study. The Lancet 2016, 386(10012):2481-2488. 6. Pandie S, Hellenberg D, Heilig F, et al.: Approach to chest pain and acute myocardial infarction. South African Medical Journal 2016, 106(3). 7. Windecker S, Kolh P, Alfonso F, et al.: 2014 ESC/EACTS Guidelines on myocardial revascularization. European Heart Journal 2014, 35:2541–2619. 8. Cahill T, Choudhury R and Riley P: Heart regeneration and repair after myocardial infarction: translational opportunities for novel therapeutics. Nature Reviews Drug Discovery 2017. 9. Bergmann O, Bhardwaj R, Bernard S, et al.: Evidence for Cardiomyocyte Renewal in Humans. SCIENCE 2009 324(5923):98-102. 10. Struthers A: Pathophysiology of heart failure following myocardial infarction. Heart 2005, 91(2):14-16. 11. Travers J, Kamal F, Robbins J, et al.: Cardiac Fibrosis: The Fibroblast Awakens. Circulation Research 2015, 2016(118):1021-1040. 12. Xin M, Olson E and Bassel-Duby R: Mending broken hearts: cardiac development as a basis for adult heart regeneration and repair. Nature Reviews Molecular Cell Biology 2013, 14:529–541. 13. Leask A: Potential Therapeutic Targets for Cardiac Fibrosis: TGF , Angiotensin, Endothelin, CCN2, and PDGF, Partners in Fibroblast Activation. Circulation Research 2010, 2010(106):1675-1680. 14. Lin Z and Pu W-T: Strategies for cardiac regeneration and repair. Science Translational Medicine 2014, 6(239). 15. Annex B and Simons M: Growth factor-induced therapeutic angiogenesis in the heart: protein therapy. Cardiovascular Research 2005, 65:649 – 655. 16. Passier R, van Laake L and Mummery C: Stem-cell-based therapy and lessons from the heart. Insight review 2008, 453(15). 17. Zlatanova I, Pinto C and Silvestre J-S: Immune Modulation of Cardiac Repair and Regeneration: The Art of Mending Broken Hearts. Frontiers in Cardiovascular Medicine 2016, 3(40). 18. Liehn E, Postea O, Curaj A, et al.: Repair After Myocardial Infarction, Between Fantasy and Reality: The Role of Chemokines. Journal of the American College of Cardiology 2011, 58(23). 19. Tkachenko E, Rhodes J and Simons M: Syndecans: New Kids on the Signaling Block. Circulation Research 2005, 96:488-500. 20. Chakravarti R and Adams J: Comparative genomics of the syndecans defines an ancestral genomic context associated with matrilins in vertebrates. BioMed Central Genomics 2006, 7(83). 21. Elfenbein A and Simons M: Syndecan-4 signaling at a glance. Journal of Cell Science 2013, 126(17):3799–3804. 22. Strand M, Aronsen J, Braathen B, et al.: Shedding of syndecan-4 promotes immune cell recruitment and mitigates cardiac dysfunction after lipopolysaccharide challenge in mice. Journal of Molecular and Cellular Cardiology 2015, 88:133–144. 23. Herum K, Lunde I, Skrbic B, et al.: Syndecan-4 signaling via NFAT regulates extracellular matrix production and cardiac myofibroblast differentiation in response to mechanical stress. Journal of Molecular and Cellular Cardiology 2013, 54:73–81. 24. Cornelison D, Filla M, Stanley H, et al.: Syndecan-3 and Syndecan-4 Specifically Mark Skeletal Muscle Satellite Cells and Are Implicated in Satellite Cell Maintenance and Muscle Regeneration. Developmental Biology 2001, 239:79–94. 25. Woods A, Longley R, Tumova S, et al.: Syndecan-4 binding to the high affinity heparin-binding domain of fibronectin drives focal adhesion formation in fibroblasts. Archives of Biochemistry and Biophysics 2000, 374(1):66-72. 26. Strand M, Herum K and Rana Z: Innate immune signaling induces expression and shedding of the heparan sulfate proteoglycan syndecan-4 in cardiac fibroblasts and myocytes, affecting inflammation in the pressure-overloaded heart. Federation of European Biochemical Societies Journal 2013, 280:2228–2247. 27. Takahashi R, Negishi K, Watanabe A, et al.: Serum syndecan-4 is a novel biomarker for patients with chronic heart failure. Journal of Cardiology 2011, 57: 325—332. 28. Xie J, Wang J, Li R, et al.: Syndecan-4 over-expression preserves cardiac function in a rat model of myocardial infarction. Journal of Molecular and Cellular Cardiology 2012, 53:250–258. 29. Tzahor E and Poss K: Cardiac regeneration strategies: Staying young at heart. Science 2017, 356:1035–1039. 30. Bednarek D, González-Rosa J, Guzmán-Martínez G, et al.: Telomerase Is Essential for Zebrafish Heart Regeneration. Cell Reports 2015, 12(10):1691–1703. 31. Nakada Y, Canseco D, Thet S, et al.: Hypoxia induces heart regeneration in adult mice. Nature 2017, 541(12). 32. Torr E, Ngam C, Bernau K, et al.: Myofibroblasts exhibit enhanced fibronectin assembly that is intrinsic to their contractile phenotype. The Journal of Biological Chemistry 2015. 33. Jaźwińska A and Sallin P: Regeneration versus scarring in vertebrate appendages and heart. Journal of Pathology 2016, 238:233–246. 34. Chablais F, Veit J, Rainer G, et al.: The zebrafish heart regenerates after cryoinjury-induced myocardial infarction. BMC Developmental Biology 2011, 11(21). 35. Pugach E, Li P, White R, et al.: Retro-orbital Injection in Adult Zebrafish. Journal of Visualized Experiments 2009(34):e1645. 36. Knorr M, Münzel T and Wenzel P: Interplay of NK cells and monocytes in vascular inflammation and myocardial infarction. Frontiers in physiology 2014, 5(295). 37. de Preux Charles A-S, Bise T, Baier F, et al.: Distinct effects of inflammation on preconditioning and regeneration of the adult zebrafish heart. Open Biology 2016, 6(160102). 38. Matsui Y, Ikesue M, Danzaki K, et al.: Syndecan-4 Prevents Cardiac Rupture and Dysfunction After Myocardial Infarction. Circulation Research 2011, 2011(108):1328-1339. 39. Wang. J, Karra R, Dickson A, et al.: Fibronectin is deposited by injury-activated epicardial cells and is necessary for zebrafish heart regeneration. Developmental Biology 2013, 382(2):427-435. 40. Pataki CA, Couchman JR and Brábek J: Wnt Signaling Cascades and the Roles of Syndecan Proteoglycans. Journal of Histochemistry & Cytochemistry 2015, 63(7):465–480. 41. Gopal S, Multhaupt HAB, Pocock R, et al.: Cell-extracellular matrix and cell-cell adhesion are linked by syndecan-4. Matrix Biology 2017, 60-61:57-69. 42. de Preux Charles A-S, Bise T, Baier F, et al.: Preconditioning boosts regenerative programmes in the adult zebrafish heart. Open Biology 2016, 6(160101). 43. Wang J-P and Hielscher A: Fibronectin: How Its Aberrant Expression in Tumors May Improve Therapeutic Targeting. Journal of Cancer 2017, 8(4):674-682. 44. Pie´rard L: ST elevation after myocardial infarction: what does it mean? Heart 2007, 93:1329–1330. 45. Huang W-C, Yang C-C, Chen I-H, et al.: Treatment of Glucocorticoids Inhibited Early Immune Responses and Impaired Cardiac Repair in Adult Zebrafish. PLoS ONE 2013, 8(6):e66613. 46. Wang J, Karra R, Dickson A, et al.: Fibronectin is deposited by injury-activated epicardial cells and is necessary for zebrafish heart regeneration. Developmental Biology 2013, 382(2). 47. Konstandin M, Toko H, Gastelum G, et al.: Fibronectin is essential for reparative cardiac progenitor cell response after myocardial infarction. Circulation Research 2013, 113(2):115-125. 48. Moerkamp A, Lodder K, van Herwaarden T, et al.: Human fetal and adult epicardial-derived cells: a novel model to study their activation. Stem Cell Research & Therapy 2016, 7(174).
|